Analysen zu Sanofi S.A.
| 08.01.24 | Sanofi Overweight | Barclays Capital | |
| 03.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 08.12.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.12.23 | Sanofi Overweight | Barclays Capital | |
| 07.12.23 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.12.23 | Sanofi Neutral | UBS AG | |
| 06.12.23 | Sanofi Sell | Deutsche Bank AG | |
| 05.12.23 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 27.11.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.11.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.11.23 | Sanofi Sell | Deutsche Bank AG | |
| 03.11.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 30.10.23 | Sanofi Overweight | Barclays Capital | |
| 30.10.23 | Sanofi Sell | Deutsche Bank AG | |
| 30.10.23 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.10.23 | Sanofi Neutral | UBS AG | |
| 27.10.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 20.10.23 | Sanofi Sell | Deutsche Bank AG | |
| 18.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 05.10.23 | Sanofi Sell | Deutsche Bank AG | |
| 03.10.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.09.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 11.09.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 05.09.23 | Sanofi Sell | Deutsche Bank AG | |
| 05.09.23 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.23 | Sanofi Sell | Deutsche Bank AG | |
| 03.08.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 01.08.23 | Sanofi Sell | Deutsche Bank AG | |
| 01.08.23 | Sanofi Neutral | UBS AG | |
| 01.08.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 31.07.23 | Sanofi Outperform | Credit Suisse Group | |
| 31.07.23 | Sanofi Sell | Deutsche Bank AG | |
| 28.07.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 21.07.23 | Sanofi Sell | Deutsche Bank AG | |
| 18.07.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 06.07.23 | Sanofi Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.07.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.07.23 | Sanofi Sell | Deutsche Bank AG | |
| 30.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Sanofi Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.06.23 | Sanofi Neutral | UBS AG | |
| 31.05.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 24.05.23 | Sanofi Sell | Deutsche Bank AG | |
| 23.05.23 | Sanofi Overweight | Barclays Capital | |
| 22.05.23 | Sanofi Neutral | UBS AG |
Aktuelle Aktienanalysen
| 13.02.25 | BMW Buy | UBS AG | |
| 13.02.25 | Cisco Neutral | UBS AG | |
| 13.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.02.25 | Carl Zeiss Meditec Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | Michelin Buy | Goldman Sachs Group Inc. | |
| 13.02.25 | Ströer Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | Ahold Delhaize Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | Deutsche Börse Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 13.02.25 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 13.02.25 | Novartis Neutral | UBS AG | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 12.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 12.02.25 | Michelin Buy | UBS AG | |
| 12.02.25 | EssilorLuxottica Neutral | UBS AG | |
| 12.02.25 | Michelin Neutral | JP Morgan Chase & Co. | |
| 12.02.25 | Michelin Hold | Jefferies & Company Inc. | |
| 12.02.25 | VINCI Buy | UBS AG | |
| 12.02.25 | Kering Verkaufen | DZ BANK | |
| 12.02.25 | TeamViewer Kaufen | DZ BANK | |
| 12.02.25 | Ceconomy St. Add | Baader Bank | |
| 12.02.25 | Redcare Pharmacy Sell | UBS AG | |
| 12.02.25 | Coca-Cola Kaufen | DZ BANK | |
| 12.02.25 | ams add | Baader Bank | |
| 12.02.25 | Coca-Cola Outperform | RBC Capital Markets | |
| 12.02.25 | Kering Sell | Goldman Sachs Group Inc. | |
| 12.02.25 | Siemens Energy Buy | Goldman Sachs Group Inc. | |
| 12.02.25 | Siemens Energy Neutral | JP Morgan Chase & Co. | |
| 12.02.25 | TUI Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.02.25 | Kering Buy | Deutsche Bank AG | |
| 12.02.25 | Novartis Buy | Deutsche Bank AG | |
| 12.02.25 | Carl Zeiss Meditec Neutral | Goldman Sachs Group Inc. | |
| 12.02.25 | Lufthansa Neutral | Goldman Sachs Group Inc. | |
| 12.02.25 | Südzucker Hold | Deutsche Bank AG | |
| 12.02.25 | NORMA Group Hold | Deutsche Bank AG | |
| 12.02.25 | TeamViewer Neutral | Goldman Sachs Group Inc. | |
| 12.02.25 | CANCOM Buy | Deutsche Bank AG | |
| 12.02.25 | Deutsche Börse Buy | Deutsche Bank AG | |
| 12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 12.02.25 | CANCOM Hold | Jefferies & Company Inc. | |
| 12.02.25 | Bechtle Buy | Jefferies & Company Inc. | |
| 12.02.25 | Ahold Delhaize Hold | Jefferies & Company Inc. | |
| 12.02.25 | Netflix Outperform | Bernstein Research | |
| 12.02.25 | PVA TePla Buy | Jefferies & Company Inc. | |
| 12.02.25 | Sixt Buy | Warburg Research | |
| 12.02.25 | National Grid Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.